Rheumatoid arthritis signaling protein reverses Alzheimer’s disease in mouse modeln — New study shows GM-CSF reduces AD pathology and eliminates memory loss – A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer’s disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease, a new study by the University of South Florida reports.
Study evaluates association of genetic factors and brain imaging findings in Alzheimer’s disease – By investigating the association between genetic loci related to Alzheimer’s disease and neuroimaging measures related to disease risk, researchers may have uncovered additional evidence that several previously studied genetic variants are associated with the development and progression of Alzheimer’s disease and also may have identified new genetic risk factors for further study, according to a report in the June issue of Archives of Neurology, one of the JAMA/Archives journals.
Fluctuating blood pressure associated with risk of cerebrovascular disease – The risk of cerebrovascular diseases appears to be higher among individuals with fluctuating blood pressure in addition to high blood pressure, according to a report in the May issue of Archives of Neurology, one of the JAMA/Archives journals.
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis – The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS).
Aerobic exercise has a better effect on cognition and other biomarkers associated with Alzheimer disease pathology for older adults with mild cognitive impairment. – Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition.
Compared with placebo, the use of G biloba, 120 mg twice daily, did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment. – Older adults who used the herbal supplement Ginkgo biloba for several years did not have a slower rate of cognitive decline compared to adults who received placebo.
Reduced muscle strength associated with risk for Alzheimer’s disease – Individuals with weaker muscles appear to have a higher risk for Alzheimer’s disease and declines in cognitive function over time, revealed by the researchers.
Problems managing money may surface shortly before Alzheimer’s disease sets in – New research finds poor money management skills may indicate that a person with mild memory problems will soon develop Alzheimer’s disease, revealed by researchers in a new research study.
High blood pressure linked to memory problems in middle age – High blood pressure is linked to memory problems in people over 45, according to research published in the August 25, 2009, print issue of Neurology?, the medical journal of the American Academy of Neurology.
New research links social stress to harmful fat deposits, heart disease – Social stress could be an important precursor to heart disease by causing the body to deposit more fat in the abdominal cavity, speeding the harmful buildup of plaque in blood vessels, a stepping stone to the number one cause of death in the world.
Biomarkers may help predict risk of Alzheimer’s disease in patients with mild cognitive impairment – Several cerebrospinal fluid (CSF) biomarkers showed good accuracy in identifying patients with mild cognitive impairment who progressed to Alzheimer’s disease, revealed by US researchers in JAMA.
White matter changes may predict dementia risk – Elderly people with no memory or thinking problems are more likely to later develop thinking problems if they have a growing amount of “brain rust,” or small areas of brain damage, revealed by researchers.
